Xenon Pharmaceuticals Inc. (XENE): $17.93

-0.23 (-1.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XENE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Xenon Pharmaceuticals Inc (XENE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XENE.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $28 $22 $25.29 $18.35 37.82%

The Trend in the Analyst Price Target


XENE's average price target has moved up $1.91 over the prior 206 days.

Over the past 331 days, XENE's average upside potential has been 69.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 7 28 22 25.29 17.97 40.73%
2021-04-17 7 28 22 25.29 19.63 28.83%
2021-03-23 7 28 22 25.29 17.51 44.43%
2021-03-20 7 28 22 25.29 18.91 33.74%
2021-03-13 7 28 22 25.29 20.55 23.07%
2021-02-01 7 25 22 23.43 15.55 50.68%
2021-01-30 7 25 22 23.43 14.35 63.28%
2021-01-23 7 25 22 23.00 15.97 44.02%
2021-01-16 7 25 22 23.00 16.06 43.21%
2021-01-09 7 25 22 23.00 15.30 50.33%
2021-01-02 7 25 22 23.00 15.38 49.54%
2020-12-04 7 25 22 23.00 11.19 105.54%
2020-11-28 7 25 22 23.00 11.40 101.75%
2020-11-20 7 24 22 22.71 11.04 105.71%
2020-11-06 8 25 22 23.00 10.97 109.66%
2020-10-01 8 25 22 23.38 11.19 108.94%
2020-08-12 7 25 22 23.57 11.25 109.51%
2020-08-07 7 25 22 23.57 11.20 110.45%
2020-07-20 6 25 22 23.67 12.81 84.78%
2020-07-05 5 25 23 24.00 12.81 87.35%
2020-05-29 6 25 23 23.83 13.70 73.94%

XENE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.12 6 2 0 0 0 8

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of XENE is higher than 70.97% of all US stocks.
  • Xenon Pharmaceuticals Inc's number of analysts covering the stock is greater than 87.43% of stocks in the small market cap category.
  • XENE has a less variance in analysts' estimates than 70.86% of Pharmaceutical Products stocks.
  • Xenon Pharmaceuticals Inc's average analyst price target is greater than 62.48% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Xenon Pharmaceuticals Inc are TVTX, IDYA and ARDX.

Is XENE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7959 seconds.